Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Fukuda Denshi Co., Ltd.

Fukuda develops and manufactures medical devices, focusing on cardiology, patient monitoring, and vascular screening products.

Metric
Company Name	Fukuda Denshi Co., Ltd.
Symbol	6.96K
MSH ID	COM:FUKUDA
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	JP
Stage
Employee Count	3.44K
Website	fukuda.com
LinkedIn
Founders

Metric
Market Cap	1.25B
Enterprise Value
Monthly Web Traffic	2.31K
Web Traffic Growth	-0.09
Valuation
Raised Capital

Metric
Revenue	910.63M
Revenue (LTM)
Revenue (NTM)
Gross Profit	471.99M
EBITDA	235.13M
Operating Income	172.02M
Net Income	121.31M
EPS	4.04
Diluted EPS	4.04
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.54
Operating Profit Margin	0.19
EBITDA Margin	0.26
Net Profit Margin	0.14
Return on Equity	0.11
Return on Assets	0.09
Return on Capital Employed	0.16

6960

COM:FUKUDA

Fukuda

Last Close

7,230.00

25/11 06:45

Market Cap

192.84B

Beta: -

Volume Today

16.20K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	13.65
P/B Ratio	1.51
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.63
EV Multiple	9.60

Metric
Days Sales Outstanding	86.95
Days Payables Outstanding	78.25
Days Inventory Outstanding	115.57
Operating Cycle	208.29
Cash Conversion Cycle	103.19
Asset Turnover	0.69

Metric
Operating Cash Flow	155.19M
Free Cash Flow	63.54M
Cash Flow to Debt	10.60
Operating Cash Flow/Sales	0.14
Free Cash Flow Yield

Metric
Cash & Equivalents	390.81M
Accounts Receivable	-51.92K
Inventory	101.60M
Goodwill
Debt to Capitalization	0.02
Debt to Assets	0.01
Current Ratio	3.86
Quick Ratio	3.25

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue